Clinical Trial Update: Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of sunitinib and radiation in patients with resectable soft tissue sarcoma; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Australasian Sarcoma Study Group | Conditions: Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN